NYSE: DPLO

-0.61 -3.91% $ 14.99 Volume: 753,507 Common Stock | 20 minute delay December 10, 2018

Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes.

Date Filing Filing Description Download
December 10, 2018 SC 13G/A Amended Statement of Ownership
November 7, 2018 10-Q Quarterly Report
November 6, 2018 8-K Current report filing

NYSE: DPLO

-0.61 -3.91% $ 14.99 Volume: 753,507 Common Stock | 20 minute delay December 10, 2018

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now